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Microcin E492 (MccE492) is a pore-forming bacteriocin produced and exported by
Klebsiella pneumoniae RYC492. Besides its antibacterial activity, excreted MccE492
can form amyloid fibrils in vivo as well as in vitro. It has been proposed that bacterial
amyloids can be functional playing a biological role, and in the particular case of
MccE492 it would control the antibacterial activity. MccE492 amyloid fibril’s morphology
and formation kinetics in vitro have been well-characterized, however, it is not known
which amino acid residues determine its amyloidogenic propensity, nor if it forms
intracellular amyloid inclusions as has been reported for other bacterial amyloids. In
this work we found the conditions in which MccE492 forms intracellular amyloids in
Escherichia coli cells, that were visualized as round-shaped inclusion bodies recognized
by two amyloidophilic probes, 2-4′-methylaminophenyl benzothiazole and thioflavin-
S. We used this property to perform a flow cytometry-based assay to evaluate the
aggregation propensity of MccE492 mutants, that were designed using an in silico
prediction of putative aggregation hotspots. We established that the predicted amino
acid residues 54–63, effectively act as a pro-amyloidogenic stretch. As in the case
of other amyloidogenic proteins, this region presented two gatekeeper residues (P57
and P59), which disfavor both intracellular and in vitro MccE492 amyloid formation,
preventing an uncontrolled aggregation. Mutants in each of these gatekeeper residues
showed faster in vitro aggregation and bactericidal inactivation kinetics, and the two
mutants were accumulated as dense amyloid inclusions in more than 80% of E. coli
cells expressing these variants. In contrast, the MccE492 mutant lacking residues 54–
63 showed a significantly lower intracellular aggregation propensity and slower in vitro
polymerization kinetics. Electron microscopy analysis of the amyloids formed in vitro
by these mutants revealed that, although with different efficiency, all formed fibrils
morphologically similar to wild-type MccE492. The physiological implication of MccE492
intracellular amyloid formation is probably similar to the inactivation process observed
for extracellular amyloids, and could be used as a mean of sequestering potentially toxic
species inside the cell when this bacteriocin is produced in large amounts.
Keywords: microcin E492, intracellular amyloids, gatekeeper residues, protein aggregation, inclusion bodies
Abbreviations: BTA-1, 2-4′-methylaminophenyl benzothiazole; MccE492, microcin E492; PBS, phosphate-buﬀered saline;
PFA, paraformaldehyde; TCA, trichloroacetic acid; ThS, thioﬂavin S.
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INTRODUCTION
Amyloid ﬁbrils are highly organized protein aggregates with a
unique quaternary structure named cross-β, consisting of protein
monomers assembled into intermolecular hydrogen bonded
β-strands placed perpendicularly to the ﬁbril axis (Chiti and
Dobson, 2006; Fowler et al., 2007). The unit of the cross-β
spine is a β-sheet bilayer with side chains within the bilayer
forming a tight “steric zipper” (Sawaya et al., 2007; Fitzpatrick
et al., 2013). Amyloids share chemical properties such as speciﬁc
binding of probes (Nilsson, 2004) as well as denaturation and
proteolysis resistance. Traditionally, amyloid-ﬁbrils formation
has been related to neurodegenerative pathologies such as
Alzheimer’s, Parkinson’s, and Huntington’s disease. However,
several examples of amyloids playing a biological role have
appeared during the last years. These “functional amyloids” have
been described in many organisms: from bacteria and fungi,
to insects, ﬁsh, and mammals (Fowler et al., 2007). The ﬁrst
reported example of a bacterial functional amyloid was curli,
a well-studied type of extracellular amyloid ﬁbrils produced
by Escherichia coli and Salmonella that participate in bioﬁlm
formation, host cell adhesion and invasion (Chapman et al., 2002;
Wang et al., 2006). Other examples include TasA produced by
the gram-positive bacteria Bacillus subtilis, where the amyloid
ﬁbrils also participate in bioﬁlm development (Romero et al.,
2010), and the ﬁlamentous bacteria Streptomyces coelicolor,
in which the aerial hyphae growth is mediated by amyloid
structures formed by the chaplin proteins (Claessen et al.,
2003).
Most examples of bacterial amyloids are extracellular. One
exceptional and interesting case is RepA, the replication initiator
protein of Pseudomonas plasmid pPS10. In the presence of
short dsDNA oligonucleotides, the RepA-WH1 domain forms
amyloid ﬁbrils in vitro (Giraldo, 2007). The expression in
E. coli of the hyper-amyloidogenic domain variant A31V
fused to a red ﬂuorescent protein, led to the accumulation
of amyloid inclusions into the cytosol. Remarkably, these
amyloid inclusions were transmitted vertically to the progeny
and bacteria carrying them showed decreased cell ﬁtness,
constituting a bacterial proteinopathy (Fernández-Tresguerres
et al., 2010). Regarding intracellular amyloid formation, it has
been found that mammalian amyloid proteins expressed in
E. coli form intracellular amyloid aggregates as well (Dasari
et al., 2011; Espargaró et al., 2012). Moreover, when analyzing
the ultrastructure of inclusion bodies formed by a growing
number of proteins (even those not formally deﬁned as
amyloidogenic), it was noticed that they have an amyloid-like
cross-β structure (Carrió et al., 2005; Wang et al., 2008a).
Additionally, it was demonstrated that the co-expression of the
yeast amyloidogenic proteins Sup35 and New1 in E. coli cells
leads to the formation of cytoplasmic inclusions with amyloid
properties, and its formation is correlated with the propagation
of the prionic/amyloid form of Sup35, termed [PSI+] (Yuan et al.,
2014).
It is now evident that proteins capable of forming amyloid
structures are quite diverse, and that the amyloidogenesis
phenomenon is more ubiquitous than originally thought. Thus, it
has been suggested that amyloid formation is a generic property
of the polypeptide chain and not a feature of a small number
of proteins (Stefani and Dobson, 2003). Moreover, it has been
shown that the propensity to form amyloid ﬁbrils depends on
speciﬁc regions or residues within the polypeptide chain. The
“pro-amyloidogenic regions” or “aggregation hotspots” initiate
or favor the conformational transition into the cross-β assembly
and often consist of 5–15 adjacent hydrophobic residues of low
net charge and a high tendency to form β-strands (Beerten
et al., 2012). In addition, aggregation propensity can also be
modulated by a group of residues called gatekeepers, located near
or within the pro-amyloidogenic region. These residues prevent
an uncontrolled aggregation disfavoring β-structure formation,
and are usually charged residues or prolines (Rousseau et al.,
2006; Beerten et al., 2012).
Microcin E492 is a low-molecular-weight channel-forming
bacteriocin produced by Klebsiella pneumoniae RYC492 (de
Lorenzo, 1984; Lagos et al., 1993, 2009). It is found in two
forms: unmodiﬁed (7,887 Da) and post-translationally modiﬁed
in its C-terminal end by the covalent linkage of glycosylated
salmochelin derivatives of diﬀerent molecular masses (Thomas
et al., 2004). This modiﬁcation is required for antibacterial
activity, since toxin uptake by the target cells depends on
the recognition of the salmochelin-like moiety by the outer
membrane catecholate siderophore receptors FepA, Fiu, and Cir
(Strahsburger et al., 2005). Once in the periplasm, MccE492
exerts its toxic activity through the formation of pores in
the cytoplasmic membrane and the consequent membrane
potential dissipation (de Lorenzo and Pugsley, 1985; Lagos
et al., 1993). One salient feature of MccE492 is its ability
to form amyloid ﬁbrils, which was observed in vitro and
in vivo in the extracellular space, and was associated with
the loss of antibacterial activity (Bieler et al., 2005; Marcoleta
et al., 2013). Hence, amyloid formation was proposed as a
mechanism of antibacterial inactivation. Even though MccE492
amyloid ﬁbril’s morphology and formation kinetics in vitro
have been well-characterized (Bieler et al., 2005; Arranz et al.,
2012; Marcoleta et al., 2013), it is not known if MccE492,
as in the case of RepA, forms amyloid in vivo inside the
cell. Besides the inﬂuence of the post-translational modiﬁcation
on retarding the kinetics of amyloid formation (Marcoleta
et al., 2013), there are no studies on how the primary
structure, speciﬁcally which amino acid residues, determines its
amyloidogenic propensity. In this work we report the conditions
in which MccE492 forms intracellular amyloid inclusions.
We used this phenomenon to perform a ﬂow cytometry-
based screen for MccE492 mutants with altered aggregation
propensity, establishing which regions and residues act as
pro-amyloidogenic regions or as gatekeepers, promoting or
disfavoring both intracellular and in vitro amyloid formation.
Additionally, our results suggest that there is a factor encoded in
the MccE492 genetic cluster that may act promoting intracellular
MccE492 amyloidogenesis. The promotion of cytoplasmic
MccE492 amyloid formation suggests that this phenomenon
may have a physiological implication as a mechanism of
capturing and inactivating an excess of toxic species inside the
bacteria.
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MATERIALS AND METHODS
Bacterial Strain and Plasmids
The bacterial strain and plasmids used in this work are shown
in Table 1. A vector for tight expression of MccE492 and
mutagenized derivatives was designed. This construct harbors
both mceA (MccE492) and mceB (immunity protein) genes
under the control of a T7 promoter, a lac operator and a T7
terminator (pETAB cassette, Figure 1A). The expression of the
immunity is required since MccE492 expression is toxic in the
absence of this protein (Bieler et al., 2006). It is important
to note that naturally, mceB and mceA (in this order) form a
single transcriptional unit where the last 23 nucleotides of mceB
and the ﬁrst 23 nucleotides of mceA overlap. Results from our
laboratory indicate that there is an internal promoter inside
the mceB coding region that contributes to the expression of
mceA. For this reason we decided to invert the order of the
genes in the cassette, and to insert a consensus ribosome binding
site to each coding region in order to achieve a comparable
expression of both genes, and to avoid leaky transcription of
mceA from the mceB internal promoter. Additionally, to allow
the easy replacement of the mceA gene by distinct variants and
the cloning of the pETAB cassette,NdeI/HindIII and BamHI sites
were conveniently included. pETAB was cloned in the p33AM
plasmid backbone generating p33pETAB, which harbors a copy
of the lacIq repressor gene and a p15A origin (Figure 1B).
Two diﬀerent plasmids compatible with the p33pETAB system,
carrying the whole or part of the MccE492 production cluster
were used in this work: pMccE492 and np220. pMccE492
comprises all the necessary components for active microcin
production, i.e., the structural and immunity genes and the genes
involved in post-translational modiﬁcation, export, regulation,
and others of unknown function, in the same disposition as
in K. pneumoniae RYC492 chromosome, as it is depicted in
Lagos et al. (2009). The expression of this plasmid results
in the production of active MccE492. Meanwhile, np220 is
a plasmid used in our lab as a background to produce and
export post-translationally modiﬁed MccE492 (Mercado et al.,
2008) expressed from a compatible plasmid, such as p33pETAB
and pBAML. np220 encodes all the components necessary
for MccE492 activity, such as immunity, export and post-
translational modiﬁcation, with a gene disposition that it is not
exactly the same than in K. pneumoniae RYC492. In this plasmid
the structural gene mceA is interrupted by a Tn5 insertion,
thus np220 by itself is unable to produce MccE492 (Lagos
et al., 2001). Another plasmid used in this work is pBAML,
which only harbors the structural mceA and the immunity mceB
genes with their natural promoter and in the conﬁguration
described above for K. pneumoniae RYC492. The expression
of pBAML as well as p33pETAB in the absence of np220
results in the production of unmodiﬁed and non-exported
MccE492.
TABLE 1 | Bacterial strain and plasmids used in this work.
Bacterial strain or plasmid Relevant genotype or features Source
Escherichia coli strain
BL21-AI F- ompT hsdSB (rB-mB-) gal dcm araB::T7RNAP tetA Invitrogen
Plasmids
pHC79 ColE1 cosmid derivative. Ampr Tetr Hohn and Collins, 1980
pMccE492 Whole MccE492 production system, pHC79 derived. Ampr González, 2011
np220 Whole MccE492 production system, but mceA::Tn5. Ampr Kanr Mercado et al., 2008
pBAML MccE492 structural (mceA) and immunity (mceB) genes. Camr Lagos R. laboratory collection
p33AM lacIq. Allows the regulation of the pET system. P15A origin, Camr Lagos R. laboratory collection
p33pETAB p33AM derivative. Contains the pETAB cassette (mceA and mceB
under the control of the T7 promoter) and lacIq. Camr
This work
N16A p33pETAB derivative. mceA was mutagenized replacing asparagine
16 by alanine. Camr
This work
P26A p33pETAB derivative. mceA was mutagenized replacing proline 26
by alanine. Camr
This work
18–35 p33pETAB derivative. mceA was mutagenized deleting amino acids
18–35. Camr
This work
P53A p33pETAB derivative. mceA was mutagenized replacing proline 53
by alanine. Camr
This work
N55A p33pETAB derivative. mceA was mutagenized replacing asparagine
55 by alanine. Camr
This work
P57A p33pETAB derivative. mceA was mutagenized replacing proline 57
by alanine. Camr
This work
P59A p33pETAB derivative. mceA was mutagenized replacing proline 59
by alanine. Camr
This work
P64A p33pETAB derivative. mceA was mutagenized replacing proline 64
by alanine. Camr
This work
54–63 p33pETAB derivative. mceA was mutagenized deleting amino acids
54–63. Camr
This work
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FIGURE 1 | Properties of the pETAB cassette for regulated expression
of MccE492. Genes mceAB were cloned under a T7 promoter with further
regulation by lac operator (A). A consensus ribosome binding site (RBS) was
included upstream of each coding region. This cassette was introduced in the
BamHI site of p33AM, generating p33pETAB (B) that expresses constitutively
lacIq, to repress expression from the T7 promoter in the absence of IPTG.
Different versions of the mceA genes can be replaced in this construction
using the NdeI/HindIII restriction fragment.
Growth Conditions
Bacterial growth was performed incubating with shaking (180–
220 rpm) at 37◦C. For confocal microscopy analysis cells
carrying MccE492 producing systems were grown inM9minimal
medium supplemented with citrate 0.2% and glucose 0.2%
for 48 h (late stationary phase). For intracellular aggregation
propensity determinations, cells carrying p33pETAB variants
with or without np220 (this plasmid allows the modiﬁcation and
exportation of MccE492) were grown in LB medium. Antibiotics
were used in the following concentrations: ampicillin (Amp)
100 μg/ml, kanamycin (Kan) 50 μg/ml, and chloramphenicol
(Cam) 50 μg/ml.
MccE492 Induction Assay
MccE492 induction assay in the p33pETAB/BL21-AI system was
performed as follows: 15 ml of LB (with the corresponding
antibiotic) were inoculated with 1:20 dilution of fresh overnight
E. coli BL21-AI p33pETAB culture. The cells were grown at
37◦C with shaking at 180 rpm until early exponential phase was
reached. At this point, 10 ml of culture were split in two (5 ml
each): one aliquot was induced with 0.2% arabinose and 1 mM
IPTG, and the other was left untreated. After 6 h, aliquots of
induced and non-induced cells were collected to continue with
the protein extraction protocol or with the ﬁxation and staining
procedure.
Total Protein Extraction
For total protein extraction, cells were centrifuged at 12,900 × g
for 10 min. The pellet was re-suspended in PBS buﬀer, incubated
at 95◦C for 20 min and centrifuged at 12,900 × g for 15 min at
4◦C. 400 μl of the supernatant were collected and 100 μl of cold
TCA were added. The mixture was incubated 10 min at 4◦C and
then centrifuged at 12,900× g for 15min at 4◦C. The supernatant
was discarded and the pellet was washed twice with 200 μl of
chilled acetone. Finally, acetone was evaporated and the pellet was
stored at −80◦C.
SDS-PAGE and Immunoblotting
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) was performed as described by Schägger and von Jagow
(1987). Nitrocellulose membranes (Millipore) were used for
immunoblot transfer (1 h, 350 mA, using chilled 25 mM Tris-
HCl, 190 mM glycine, 20% methanol, as the transfer buﬀer).
MccE492 was detected with a polyclonal antibody prepared
in rabbit against the last 20 amino acids of the protein
(antiserum dilution, 1:1,000) and with a goat anti-rabbit alkaline
phosphatase-conjugated secondary antibody (dilution 1:5,000).
The alkaline phosphatase colorimetric reaction was performed
as described by Marcoleta et al. (2013). The membrane was
washed with FAL buﬀer (100 mM Tris-HCl [pH 9.5], 100 mM
NaCl, 5 mM MgCl2) and incubated in 10 ml of a mixture of
BCIP (5-bromo-4-chloro-3′-indolylphosphate p-toluidine salt)
and NBT (nitroblue tetrazolium chloride; 0.3 and 0.15 mg/ml
in FAL buﬀer, respectively), until an optimal signal was
observed.
Cell Fixation and Staining for Confocal
Microscopy
Five hundred μl of bacterial culture were washed twice with the
same volume of PBS buﬀer by centrifuging at 1,100× g for 4 min
at room temperature, ﬁxed by suspending in 250 μl of 4% PFA
in PBS and incubating for 30 min at room temperature. BTA-
1 staining was performed as described (Fernández-Tresguerres
et al., 2010). After ﬁxation, cells were washed twice with 250 μl
of PBS buﬀer by centrifuging at 1,100 × g for 4 min at room
temperature, re-suspended in 1 mM BTA-1 prepared in 100%
ethanol, and incubated for 30 min at room temperature. Finally,
cells were washed twice with PBS. ThS staining was carried out
based on the protocol of Espargaró et al. (2012) with some
modiﬁcations: 500 μl of bacterial culture were centrifuged at
1,100 × g for 4 min at room temperature, the supernatant was
discarded, and the bacterial pellet was washed twice with 500 μl
of PBS buﬀer. Cells were suspended in 250 μl of 0.05% (w/v) ThS
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in 12.5% ethanol and incubated for 1 h at room temperature. We
found that ThS staining in the presence of 12.5% ethanol, instead
of PBS as originally described, leads to a smaller number of false
negative cells. After staining, cells were washed three times with
250μl of PBS buﬀer. Stained cells were mounted over a glass slide
covered by layer of 1% agarose in PBS.
Confocal Microscopy
Microscopic observations were performed using an LSM 710
(Zeiss) confocal microscope, with a 63x/NA 1.40 oil immersion
objective. ThS ﬂuorescence was excited using a 488 nm argon
laser and the emission was registered in a range from 410 to
520 nm. BTA-1 ﬂuorescence was excited with a 405 nm laser
diode and the emission was registered between 493 and 552 nm.
Images were digitally captured with ZEN 2012 and analyzed with
ImageJ software (Schneider et al., 2012).
Flow Cytometry
Thioﬂavin-S staining for ﬂow cytometry analysis was carried
out in the same way as described for confocal microscopy, but
starting with unﬁxed cells. Flow cytometry measurements were
performed using a BD FACSCantoTM II ﬂow cytometer. Cells
stained with ThS were ﬁrst gated by forward scatter (FSC) and
side scatter (SCC) signals, and then analyzed for ThS ﬂuorescence
by exciting at 405 nm and registering the emission at 510/550 nm.
MccE492 Purification
MccE492 (wild-type or mutant) was puriﬁed from culture
supernatants of E. coli BL21-AI cells carrying each p33pETAB
variant along with np220, to allow MccE492 processing and
export. Brieﬂy, 4 L of M9 medium supplemented with 0.2%
citrate and 0.1% glucose were inoculated with 1:1000 dilution
of fresh overnight culture and grown at 37◦C with shaking at
180 rpm for 6 h (until exponential phase). At this point, 0.2%
arabinose and 1 mM IPTG were added. After 12–14 h, the
supernatant was collected by centrifugation and ﬁltered through a
0.22 μm polyethersulfone membrane. The cell-free medium was
incubated with 25 g of previously ACN-activated Bondapak C18
resin (Waters) at 4◦C for 2 h. The resin was ﬁltered by negative
pressure through a Buchner funnel, washed with 200 ml of 40%
methanol, then with 200 ml of 25% ACN, and ﬁnally eluted with
a 30–100% ACN stepwise gradient. MccE492-enriched fractions
were dialyzed twice for 2 h against 40 volumes of 5 mM Tris (pH
8.5) and then lyophilized and stored at−20◦C.
In vitro MccE492 Amyloid Formation
followed by Congo Red Binding Assay
An appropriate amount of lyophilized MccE492 powder was
dissolved in 5 mM Tris (pH 8.5), and centrifuged for 30 min at
16,000 × g to eliminate preformed aggregates. The supernatant
was diluted to 0.4 mg/ml in the aggregation buﬀer (100 mM
PIPES-NaOH, 0.5MNaCl [pH 6.5]) and incubated with agitation
(800 rpm) during the entire assay. Amyloid formation was
quantiﬁed by the diminution of free Congo red using the
following procedure: at the indicated times, MccE492 samples
were incubated at 37◦C for 15 min with 33 μM Congo red and
centrifuged at 16,000 × g for 40 min at 4◦C. The supernatant
absorbance was registered at 490 nm, and the free Congo red
fraction was determined as the ratio between the absorbance
registered at each time and the absorbance at time zero.
Determination of Soluble MccE492
During the Aggregation Curve
To visualize soluble MccE492 during the aggregation assays,
aliquots of the samples taken at diﬀerent times were collected
and centrifuged at 16,000× g for 40 min at 4◦C. The supernatant
was recovered and the remaining soluble protein was detected by
SDS-PAGE and immunoblotting.
MccE492 Antibacterial Activity
Determination
MccE492 activity was determined by the critical dilution method
(Mayr-Harting et al., 1972). At the indicated times, aliquots from
the aggregation assays were collected and serially diluted in sterile
nanopure water. Three μl of each dilution were seeded onto
a lawn of a sensitive E. coli strain, prepared by mixing 0.3 ml
of the E. coli culture with 3 ml soft agar and overlaying the
resulting mixture onto LB plates. MccE492 antibacterial activity
was detected by the formation of growth inhibition halos, and
the activity was expressed in arbitrary units based on the highest
dilution in which a halo was observed.
Electron Microscopy
Samples from the MccE492 aggregation assays were placed onto
300-square-mesh copper-rhodium grids coated with carbon and
negatively stained with 2% uranyl acetate. Micrographs were
taken in a JEOL 1200EX microscope with a tungsten ﬁlament
operated at 80 kV and with a 50,000X magniﬁcation.
RESULTS
Microcin E492 forms Intracellular
Amyloid Aggregates in E. coli Cells
It has been shown that amyloidogenic proteins from diﬀerent
origins, when expressed in E. coli, are accumulated as cytoplasmic
inclusions of amyloid nature (Fernández-Tresguerres et al.,
2010; Dasari et al., 2011; Espargaró et al., 2012). Extracellular
MccE492 amyloid formation has been observed under several
conditions, but it is not known if there is amyloid aggregation
in the cytoplasm. To investigate this possibility, E. coli cells
carrying three diﬀerent constructions expressing the whole, or
part of the genetic cluster encoding for the production of active
MccE492 were grown in M9 minimal medium at 37◦C until late-
stationary phase. After harvested, cells were ﬁxed with 4% PFA,
stained with the probes BTA-1 and ThS that speciﬁcally bind
to amyloid aggregates, and visualized by confocal microscopy
(Figure 2). Cells carrying pMccE492, a plasmid that encodes
for the whole MccE492 gene cluster that includes not only the
structural and immunity genes but all those necessary for export
and maturation, contained a variable number of cytoplasmic
inclusions that were visible under bright-ﬁeld imaging, and that
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FIGURE 2 | Microcin E492 accumulates as cytoplasmic amyloid inclusions in Escherichia coli cells expressing the whole MccE492 genetic cluster.
E. coli cells expressing totally or part of the components of the MccE492 cluster, were grown until stationary phase, stained with the amyloidophilic probes ThS or
BTA-1, and visualized by confocal microscopy. Scale bar: 5 μm. pHC79 is the vector used in the constructions pMccE492 and np220.
were recognized by both amyloidophilic ﬂuorescent probes as
round-shaped foci. These inclusions of amyloid nature were
heterogeneous in form and size, and were located at distinct
positions of the major axis of the cells (not only at the poles), as
reported previously for the hyper-amyloidogenic variant of the
WH1 domain of RepA protein from P. aeruginosa (Fernández-
Tresguerres et al., 2010). Unexpectedly, cells carrying pBAML
(comprising only the MccE492 and its immunity genes) that do
not export MccE492, did not accumulate inclusions, and behaved
as E. coli cells carrying the pHC79 control vector. Cells carrying
np220, a plasmid expressing the whole gene cluster with the
exception of the structural gene of MccE492 that is interrupted
by Tn5, showed a few cells with single polar inclusions that were
recognized by both amyloidophilic probes, indicating that most
of the inclusions observed in the wild type construct are produced
by the expression of the mceA gene. This was corroborated
upon complementation of the mutant np220 with themceA gene
from pBAML. Cells carrying both plasmids restored the multiple
amyloid inclusions phenotype caused by pMccE492 (Figure 2).
Interestingly, the accumulation of MccE492 amyloid
inclusions is accompanied with a polymorphism in the cell
length. There is a minority of cells that form ﬁlaments with
a length equivalent to the sum of more than 15 normal cells
(Supplementary Figure S1) that can harbor up to 20 amyloid
foci. This suggests that massive amyloid accumulation could
someway interfere with the septation process, although it
remains unclear why this occurs only in a minor fraction of the
bacterial population.
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Identification of Amino Acid Residues
and Regions Potentially Involved in
MccE492 Amyloid Formation
One central aspect on the study of amyloid formation is how
the primary structure of a protein inﬂuences the ﬁbril formation
process, and the identiﬁcation of regions and residues that
may act promoting or disfavoring its occurrence. Based on
the evaluation of distinct physicochemical properties of its
residues, several algorithms have been developed to predict and
identify aggregation hotspots inside the primary structure of
amyloidogenic proteins (Chiti et al., 2003; Fernández-Escamilla
et al., 2004; López de la Paz and Serrano, 2004; Maurer-Stroh
et al., 2010; Tsolis et al., 2013). In order to identify putative
aggregation hotspots of MccE492, we analyzed its sequence
with the AMYLPRED2 web tool, which employs a consensus
of 11 diﬀerent methods and algorithms that predict features
related to the formation of amyloid ﬁbrils (Tsolis et al., 2013).
Analysis of theMccE492 protein sequence showed that the region
comprising residues 57–63 of the processed peptide, especially
residues 60–62, has the highest consensus being recognized as
pro-amyloidogenic by six diﬀerent algorithms (Figure 3). This
region contains several hydrophobic residues (IPVLIG), some
of which (VLI) are very commonly found in pro-amyloidogenic
regions of several proteins (López de la Paz and Serrano, 2004).
Also, inside and near to this region there are several proline
residues (P53, P57, P59, P64), which are β-strands disruptors
that normally act as “amyloid gatekeepers” diminishing the
overall aggregation propensity of the protein (López de la Paz
and Serrano, 2004; Beerten et al., 2012). An asparagine residue
(N55) was found near to the predicted hydrophobic aggregation
hotspot, that due to its polar nature could also act as a gatekeeper.
The authors of AMYLPRED2 suggest at least a consensus of ﬁve
for a reliable prediction. However, the region between residues
20–24 that is recognized only by four algorithms (Figure 3) was
considered as a secondary amyloidogenic region for the following
reasons: ﬁrst, MccE492 region encompassing residues 16–38
presents 57% of identity and 74% of similarity with the prion
PrP protein regions 111–133 (Baeza, 2003); second, this region
is also hydrophobic and it is ﬂanked by the putative gatekeeper
residues asparagine (N16) and proline (P26). To test these
predictions, MccE492 mutants in the residues mentioned above
and deletions of the corresponding regions were constructed and
its amyloidogenic properties were studied.
Quantitation of the Proportion of Cells
Carrying MccE492 Intracellular
Amyloids, Evaluation of Variants with
Altered Amyloidogenic Properties, and
Identification of Amino Acid Residues
Regulating Intracellular Amyloid
Formation
Intracellular MccE492 amyloid formation is a phenomenon
that can be exploited to implement a fast and simple method
for the screening of MccE492 mutants with altered amyloid-
formation properties. A comprehensive analysis of these mutants
should allow the identiﬁcation of protein regions controlling
the aggregation propensity, providing new insights of how
MccE492 amyloid formation occurs. Based on an assay described
by Espargaró et al. (2012), we used ThS-staining and ﬂow
cytometry analysis to quantitate the proportion of cells harboring
cytoplasmic amyloid inclusions upon expression of distinct
MccE492 variants. In this way, we were able to measure and
compare the amyloid formation propensity of each variant
and consequently, to evaluate the relevance of the mutated
residue or region in the aggregation process. As a ﬁrst step,
the assay setup required the design and construction of a
tightly regulated expression system, which allowed a comparable
expression of each MccE492 variant when induced for a
deﬁned time lapse. For this purpose, we synthesized the pETAB
expression cassette (Figure 1, see Materials and Methods)
that was ligated to the p33AM plasmid generating p33pETAB.
From here, mceA gene can be easily replaced by the variants.
These constructions were transformed into E. coli BL21-AI
cells, which expresses the T7 polymerase only after induction
with arabinose, therefore MccE492 expression from this system
requires the concomitant action of IPTG and arabinose as
inductors.
To ascertain that this regulated expression systemwas working
as expected, we tested six random clones of the wild-type form
that were induced by incubating them with arabinose and IPTG
during 4 h. SDS-PAGE-Immunoblot of total protein extracts
showed a prominent band corresponding to MccE492 only in
the induced samples (Supplementary Figure S2). In addition, the
antibacterial activity of the expressed MccE492 was assessed by
co-transformation of the E. coli BL21-AI p33pETAB strain with
the compatible plasmid np220 (mutated in mceA), that provides
all the elements required for MccE492 maturation and export.
The production of functional active MccE492 of six clones was
detected as the presence of growth-inhibition halos over a layer
of sensitive bacteria (Supplementary Figure S2). The toxic activity
was notably higher in presence of the inducers.
Based on the information provided by the in silico prediction,
we designed a collection of MccE492 variants with substitutions
or deletions of speciﬁc amino acids. We hypothesized that
if the predicted regions act as pro-amyloidogenic stretches,
deletion of these regions should diminish aggregation propensity,
while substitution of the corresponding putative gatekeeper
residues should increase it. Based on this, seven putative
gatekeeper residues were individually substituted by alanine
(Figure 3, black arrows) and two deletion mutants, 18–35
and 54–63, were generated. All these variants were cloned
in p33pETAB and transformed in E. coli BL21-AI cells. To
evaluate and compare the intracellular aggregation propensity
of each variant, their expression was induced for 6 h, and
then the cells were stained with ThS and analyzed by ﬂow
cytometry. Thus, we determined the proportion of cells carrying
amyloid inclusions that were recognized by the dye (Figure 4).
Expression of wild-type MccE492 led to a very low proportion
of cells carrying amyloid inclusions (∼3%), indicating that
this protein by itself does not produce a signiﬁcant amount
of amyloid aggregation in the cytoplasm (Figure 4, pETAB).
This is in agreement with the absence of inclusions observed
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FIGURE 3 | AMYLPRED2 analysis of MccE492 amino acid sequence revealed putative hydrophobic aggregation hotspots. The region encompassing
residues 57–63 was recognized as pro-amyloidogenic by six different algorithms (highest consensus score in this sequence). A second region (19–25) was
recognized with a lower consensus (only four different algorithms). β-strand disruptors (proline) and polar residues flanking or interrupting predicted hotspots
(putative aggregation gatekeepers) are shown in red and pointed with black arrows. With this information, a collection of mutants was generated, in which putative
gatekeeper residues were individually substituted by alanine, and the two regions comprising putative aggregation hotspots (18–35 and 54–63) were deleted.
in cells carrying pBAML, expressing only the MccE492 and
its immunity protein (Figure 2). Strikingly, variants P57A and
P59A formed intracellular amyloids in a very high proportion
of cells (∼80%), indicating that substitution of those residues
leads to a signiﬁcant increase in the MccE492 aggregation
propensity. This observation shows that both proline residues act
as amyloid gatekeepers disfavoring MccE492 amyloid formation.
The substitution by alanine of N16, P26, P53, N55, and P65 did
not have a signiﬁcant eﬀect on intracellular amyloid formation,
suggesting that these amino acids have a minor or no role
controlling MccE492 amyloidogenesis.
Since wild-type protein expression led to a very small amount
of ThS-positive cells, at this stage we were not able to evaluate
if the deletions of the predicted aggregation hotspots aﬀect
MccE492 intracellular aggregation propensity. Considering that
more inclusions were observed in cells expressing MccE492 in
presence of the other components encoded in the MccE492
genetic cluster (Figure 2), the expression of the wild-type
MccE492 and its variants was induced in cells carrying np220
(Figure 4, pETAB+np220). In this condition, a signiﬁcantly
higher proportion of cells accumulating inclusions upon
expression was observed in most of the variants tested. Wild-
type MccE492 intracellular amyloid was detected in nearly 40%
of the cells, and an indistinguishable behavior was found for all
the mutants except for P57A, P59A, and 54–63. A signiﬁcant
reduction of aggregation propensity was observed in the variant
with the deletion of residues 54–63 (p < 0.0001), while the
deletion of residues 18–35 had no eﬀect. On the other hand,
P57A and P59A mutants maintained the high tendency to
form aggregates, although co-transformation with np220 did not
increase the proportion of cells accumulating amyloids. This
proportion seems to be near the maximum detectable by this
method, since no higher frequency was observed in any of the
experiments performed, not even with longer induction times
(data not shown). The intracellular amyloid formation in these
assays was always dependent on the expression of MccE492,
since a very low proportion of ThS-positive cells were observed
in all the uninduced samples and in the induced cells carrying
just the vector p33AM, either alone or co-expressed with np220
(Figure 4A and Supplementary Figure S3). This observation
suggests that the increase in the frequency of ThS-positive cells
caused by np220 co-expression could be due to a synergistic eﬀect
between MccE492 and a cluster-encoded factor, and not to an
independent aggregation of this putative factor.
To further investigate the eﬀect on cell morphology and
distribution of the intracellular amyloid detected by ThS-staining
and ﬂow cytometry, cells expressing wild type MccE492 from
p33pETAB and the identiﬁed hypo- and hyper-amyloidogenic
variants were induced for 6 h, stained with either BTA-1
or ThS, and visualized by confocal microscopy (Figure 5).
In agreement with the ﬂow cytometry measurements, cells
expressing only wild-type MccE492 from p33pETAB showed
none or one very weakly stained intracellular inclusion. A similar
situation was observed with 54–63, where a faint homogeneous
ﬂuorescence was detected upon staining. In contrast, a variable
number of inclusions were observed in cells expressing variants
P57A and P59A, which showed up under bright-ﬁeld imaging
and were recognized by both amyloidophilic dyes as intense
ﬂuorescent foci. These foci were located in diﬀerent regions/areas
of the cells and had diﬀerent shapes and sizes. Moreover,
accumulation of MccE492 inclusions came together with some
degree of cell length polymorphism, with a small proportion
of cells experimenting a dramatic ﬁlamentation and harboring
more than 30 amyloid foci (Supplementary Figure S4), as
also seen in cells carrying the whole MccE492 production
cluster (Figure 2 and Supplementary Figure S1). As expected,
the hyper-amyloidogenic variants as well as the wild-type
MccE492 formed amyloid inclusions in cells carrying np220
(Supplementary Figure S5). In contrast, none or one faint
polar inclusion per bacteria was observed in cells carrying
np220 and expressing the 54–63 mutant. Taken together, these
results indicate that the region 54–63 of MccE492 has a major
role controlling intracellular amyloid formation, encompassing
hydrophobic residues that likely form the amyloid core, and two
proline β-strand disruptors that act as aggregation gatekeepers.
Additionally, at least in the conditions tested, a cluster-encoded
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FIGURE 4 | MccE492 region 54–63 and residues P57 and P59 control in vivo amyloid formation. MccE492 mutants of putative gatekeeper residues or
lacking predicted aggregation hotspots were expressed in E. coli BL21-AI cells, followed by ThS staining. Bacterial cell populations carrying MccE492 amyloid
inclusions (ThS-positive) were quantitated by flow cytometry. (A) ThS-positive population frequency upon expression of different MccE492 variants in the absence
(top), or co-transformed with np220 (bottom). (B) Representative histograms of flow cytometry data obtained for cells expressing wild-type MccE492 or variants with
altered aggregation propensity, either in the absence or co-transformed with np220. Error bars show the standard deviation from three independent experiments.
∗∗∗p < 0.0001. An average of 10000 events were counted per flow cytometry run. p33AM is the vector in which the cassette pETAB was cloned.
factor is likely to act promoting MccE492 intracellular amyloid
formation.
Residues P57 and P59 of MccE492
Control In vitro the Kinetics of Amyloid
Formation and Loss of Antibacterial
Activity
To evaluate if the MccE492 aggregation hotspot and the
gatekeeper residues identiﬁed in the in vivo assays are also
relevant for the in vitro ﬁbrils formation, we puriﬁed wild-type
MccE492 and the variants P57A, P59A, and 54–63 from the
supernatants of induced E. coli BL21-AI cells carrying np220
and p33pETAB. Lyophilized MccE492 samples of each variant
were dissolved in aggregation buﬀer to a ﬁnal concentration of
200μg/ml and incubated at 37◦C with constant shaking for up to
72 h. Amyloid formation kinetics were followed for each variant,
monitoring Congo red binding (Figure 6A) and determining
solubleMccE492 by SDS-PAGEand immunoblotting (Figure 6B)
at diﬀerent times. Both Congo red binding and immunoblotting
showed that most of the wild-type MccE492 remained soluble
until 8 h and was completely aggregated at 24 h. In contrast,
P57A and P59A variants aggregated signiﬁcantly faster. Part
of P57A was aggregated at the beginning of the incubation,
and was practically completely aggregated at 2 h. The P59A
variant also presented a reduced lag phase. It began to
aggregate at 2 h, and was almost completely aggregated at
8 h, showing a more gradual aggregation kinetics than P57A.
On the other hand, the mutant lacking the 54–63 pro-
amyloidogenic region aggregated slower than the wild-type
MccE492, and soluble protein was still detected even after 72 h
of incubation.
Previous studies demonstrated that MccE492 amyloid
formation causes loss of antibacterial activity (Bieler et al., 2005;
Marcoleta et al., 2013). However, it is not known which MccE492
residues conform the toxic domain, nor if these residues are also
important for amyloid formation. To gain further information
about this, we tested the antibacterial activity of all the MccE492
mutants generated in this study (Supplementary Figure S6),
stabbing colonies of E. coli expressing np220 and p33pETAB
variants over a layer of sensitive bacteria grown in plates with
or without the inducers. Growth inhibition halos were observed
in wild-type MccE492, and mutants N16A, P26A, P53A, N55A,
P57A, and P59A. On the other hand, 54–63, 18–23, and
P64A lacked antibacterial activity, since no growth inhibition
halos were observed. These results indicate that the regions
encompassing residues 18–23 and 54–64 are somehow required
for the antibacterial activity, while residues N16, P26, P53, N55,
P57, and P59 seem to be dispensable.
To evaluate if the increased polymerization propensity of
the hyper-amyloidogenic variants correlate with a faster toxin
inactivation, we titrated the antibacterial activity during the
aggregation assay described above using the critical dilution
method (Figure 6C). We observed that although both P57A and
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FIGURE 5 | Formation of amyloid inclusions in E. coli cells expressing MccE492 variants with altered aggregation propensity. p33pETAB constructs
expressing different variants of MccE492 were transformed into E. coli BL21-AI cells. After 6 h of induction, cells were fixed with PFA, stained with either
BTA-1 or ThS and visualized by confocal microscopy. Scale bar: 5 μm.
P59Amutants had antibacterial activity, the initial titer was∼20-
fold lower than wild-type MccE492. As expected, inactivation and
polymerization kinetics showed a close correlation, being the loss
of the antibacterial activity of the hyperamyloidogenic variants
signiﬁcantly faster.
The Fibrils formed by Wild-Type
MccE492 and the Variants P57A and
P59A have a Similar Morphology
In vivo and in vitro assays showed that P57A and P59A
variants present a higher propensity to form ﬁbrils with faster
polymerization/inactivation kinetics. However, it is indispensable
to know the morphology of the aggregates formed by the variants,
to ascertain that they form amyloid ﬁbrils. To this end, samples
of the in vitro aggregation assay were analyzed by negative-
stain TEM (Figure 6D). The results were consistent with those
observed using Congo red. A few short ﬁbrils and globular
aggregates of the wild-type MccE492 were observed at 6 and
8 h, while longer mature ﬁbrils with a width of about 10–12 nm
were observed at 24 h, as reported previously (Bieler et al., 2005;
Arranz et al., 2012; Marcoleta et al., 2013). On the other hand,
the amyloid ﬁbrils formed by both proline mutants presented
the same morphology than the wild-type protein, although with
an accelerated kinetics of formation. For P57A, short ﬁbrils and
globular aggregates were observed even without incubation (time
0), whereas longer mature ﬁbrils were observed at 2 h and in the
remaining time points analyzed. In the case of P59A, no ﬁbrils
were detected at time 0, but long ﬁbrils were observed after 2 h of
incubation (Figure 6D).
Regarding the 54–63 mutant, TEM analysis of samples
collected at the end of the aggregation assay showed that, despite
its decreased aggregation propensity and slower polymerization
kinetics, this mutant retains its ability to form ﬁbrils with a similar
morphology to the wild-typeMccE492 (Figure 7A). This suggests
that this region is not essential for amyloid formation, and
probably there is a secondary aggregation hotspot that could act
nucleating amyloid polymerization, although less eﬃciently. The
ability to form amyloid ﬁbrils was also assessed for the mutant
18–35, that in vivo did not present alterations in amyloid
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FIGURE 6 | In vitro amyloid polymerization of MccE492 variants with altered aggregation propensity. MccE492 variants (0.4 mg/ml) were incubated in
aggregation buffer (see Materials and Methods) and the polymerization progress was evaluated during the time using Congo red binding (A), and visualizing the
remaining soluble MccE492 (after centrifuging the samples at 16000 × g during 40 min) through SDS-PAGE- Immunoblot (B). In addition, the antibacterial activity
was determined at each time (C), and the morphology of the fibrils was studied by negative-stain electron microscopy (D). Error bars show the standard deviation
from three independent experiments. Scale bar: 100 nm.
formation. As expected, typical amyloid ﬁbrils although a little
more relaxed were formed (Figure 7B).
DISCUSSION
Currently, understanding of amyloid formation is experiencing a
change of paradigm. Traditionally, amyloids have been associated
with pathological manifestations of neurodegenerative diseases
in mammals, but today it is being recognized as a widespread
phenomenon with examples from all domains of life (Fowler
et al., 2007; Otzen, 2010; Invernizzi et al., 2012). Remarkably,
microbes ended up being very successful in controlling and
adapting amyloid formation to perform diﬀerent functions
(Hufnagel et al., 2013; Schwartz and Boles, 2013; Romero
and Kolter, 2014), although they still remain vulnerable to
the deleterious eﬀects of uncontrolled aggregation (Fernández-
Tresguerres et al., 2010; Beerten et al., 2012; Gasset-Rosa et al.,
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FIGURE 7 | MccE492 mutants 18–35 and 54–63 preserve the ability
of forming amyloid fibrils in vitro. Negative-stain electron microscopy
visualization of amyloid fibers formed by the MccE492 variants 54–63 (A) or
18–35 (B), incubated in aggregation buffer until the indicated time. Scale
bar: 100 nm.
2014). MccE492 represents a particular case of what has been
deﬁned as a functional amyloid, where the extracellular ﬁbrils
formation acts as a mechanism to control the antibacterial
activity. In this study, we addressed two major aspects previously
unexplored: ﬁrst, if MccE492 could undergo amyloid aggregation
in the cytoplasm of producing cells; and second, which regions or
residues are involved in controlling MccE492 amyloid formation.
Our results showed that wild-type MccE492 has a low
tendency to form intracellular amyloid, being barely detectable
in cells over-expressing this gene. However, its occurrence
was highly increased when a plasmid carrying the rest of
the MccE492 cluster components was co-transformed, or
when MccE492 hyperamyloidogenic variants were expressed. As
seen for other amyloidogenic proteins like RepA, cytoplasmic
MccE492 amyloid was accumulated as dense inclusion bodies of
variable shape, size, and number per cell (Fernández-Tresguerres
et al., 2010). This observation was exploited to perform
a screening for MccE492 mutants with altered aggregation
propensity, establishing that the region comprising residues
57–63, recognized as pro-amyloidogenic by the AMYLPRED2
prediction tool, eﬀectively acts as an aggregation hotspot.
Deletion of this region caused a signiﬁcant decrease in MccE492
intracellular aggregation propensity and the slow down of in vitro
ﬁbril formation kinetics. The identiﬁed aggregation hotspot
harbors VLI residues that likely form the β-strand core for
amyloid assembly, as demonstrated for other amyloidogenic
proteins (López de la Paz and Serrano, 2004). In addition, P57 and
P59 residues that are inside this region, probably act as β-strand
disruptors, disfavoring MccE492 amyloid formation. Indeed,
alanine-substitution of each of these residues dramatically
increased MccE492 aggregation propensity in vivo, and fastened
in vitro ﬁbril formation kinetics. The control of amyloid
formation by gatekeeper residues seems to be a common strategy
for diﬀerent amyloids, since analysis of Homo sapiens and
E. coli proteomes showed that the positions ﬂanking aggregating
stretches are enriched with residues such as lysine, arginine,
glutamate, aspartate and proline. Strikingly, 90% of the 26,000
pro-amyloidogenic segments found in the E. coli proteome
have at least one of these ﬁve residues at the ﬁrst position on
either side of the segment (Rousseau et al., 2006). Moreover,
gatekeeper residues can be redundant, i.e., they are present
several times in the same protein. Thus, aggregating regions
from key human proteins such as p53 or huntingtin protein are
among the most extensively gate-kept sequences, with a strong
enrichment of mutations that disrupt gatekeeper motifs in a set
of disease-associated mutations listed in the UniProt database
(Reumers et al., 2009). The ﬁrst four of the abovementioned
gatekeeper amino acids are at the bottom of diﬀerent aggregation
propensity scales, mainly as a consequence of their very low
hydrophobicity, charge and low β-sheet propensity (Monsellier
and Chiti, 2007). Proline, as mentioned previously, is considered
a β-strand breaker since its conformational rigidity imposes
spatial constraints to the cross-β folding. A more speciﬁc role of
this residue in regulating amyloid formation has been proposed,
where cis to trans isomerization can act as an intrinsic molecular
switch modulating aggregation propensity. It has been shown
that the peptidyl prolyl cis/trans isomerase cyclophilin A causes
a prolongation of the lag phase and an increase in the yield
and length of ﬁbrils formed by the human amyloidogenic
protein steﬁn B (Smajlovic´ et al., 2009). Additionally, structural
and biochemical characterization of early intermediates of β2-
microglobulin folding revealed that a cis to trans isomerization
of proline 32 is determinant in the onset of amyloid formation
of this protein (Eichner and Radford, 2009), while a similar
role of proline isomerization was observed for Ribonuclease A
amyloidogenesis (Miller et al., 2010). Understanding the nature
of the proline-gatekeeping of MccE492 amyloid formation will
provide further information about how this process is regulated
and in which circumstances it is favored. The relatively high
amount of proline residues found in MccE492 (six), four of
them located near to the identiﬁed aggregation hotspot, supports
the relevance of this amino acid in the modulation of MccE492
amyloidogenesis. It is important to note, however, that the
position and sequence context of these residues seems to be
determinant, since mutation of only P57 and P59 but not the
rest of the proline residues caused a detectable alteration in the
aggregation propensity.
Electron microscopy analysis showed that although with a
diﬀerent eﬃciency, MccE492 mutants P57A, P59A, and even that
Frontiers in Microbiology | www.frontiersin.org 12 January 2016 | Volume 7 | Article 35
Aguilera et al. Amino Acids Modulating MccE492 Amyloidogenesis
lacking residues 54–63, are able to form ﬁbrils morphologically
similar to those formed by the native protein. This latter
observation suggests that an alternative group of residues could
act as a pro-amyloidogenic region. One possibly, is the region
comprising residues 19–25, which was detected with a lower
consensus by the AMYLPRED2 tool. This region also harbors
hydrophobic residues ﬂanked by a polar residue (N) and
a proline, which qualify as putative aggregation gatekeepers.
Additionally, this group of residues is located inside a region (16–
37) that has 74% similarity with a portion of the prion-forming
domain of the human prion protein (PrP), and also comprises an
imperfect repeat of amino acid residues (21-AALGAPGG-28 and
32-AALGAAGG-39). Curiously, the only diﬀerent amino acid
(in bold) is a proline/alanine, surrounded by non-polar residues.
It has been shown that amyloid formation of the CsgA protein
(coding major curli subunit) is determined by ﬁve imperfect
repeats (R1–R5), where only R1 and R5 promote responsiveness
to CsgB nucleation and self-seeding by CsgA ﬁbers (Wang and
Chapman, 2008; Wang et al., 2008b). Repeats R2–R4 comprise
speciﬁc aspartic and glycine residues that reduce the aggregation
propensity, and thus modulate polymerization eﬃciency and
potential toxicity (Wang et al., 2010). CsgAmutants lacking those
gatekeeper residues polymerized in vitro signiﬁcantly faster than
wild-type protein, and remarkably, polymerized in vivo even
in absence of its nucleator CsgB. This points out the possible
relevance of the region 19–37 for MccE492 amyloidogenesis.
Nevertheless, deletion of residues 18–35 did not aﬀect the
intracellular amyloid formartion propensity (Figure 4), and
the in vitro aggregation products were typical amyloid ﬁbrils
(Figure 7). Also, a mutant carrying substitution P26A (rendering
a perfect repeat) showed the same intracellular aggregation
behavior than the wild-type protein. A similar situation was
observed when the alanine 37 was substituted by a proline (data
not shown), arguing against the signiﬁcance of the repeats. In
spite of the evidence abovementioned, it cannot be excluded
that this region may act leading MccE492 amyloid formation in
the absence of the primary aggregation hotspot. Taken together,
these results point out the very robust amyloidogenic capacity of
MccE492, which is kept even after deleting 18 out of 42 residues
of its N-terminal half, or at least 10 out of 42 residues of its
C-terminal half.
In agreement with previous reports, MccE492 amyloid
formation correlated with the loss of antibacterial activity (Bieler
et al., 2005; Marcoleta et al., 2013). The hyperamyloidogenic
variants P57A and P59A retained the antibacterial activity but
displayed signiﬁcantly faster inactivation kinetics (Figure 6 and
Supplementary Figure S6). This observation suggests that these
residues are dispensable for the pore-forming activity, and that
through these mutations it is possible to modulate how long the
toxin remains active. From this, it is plausible that alternative
substitutions of the gatekeeper residues could generate a battery
of toxin variants with diﬀerent inactivation kinetics.
We found that MccE492 intracellular amyloid formation
was observed in three circumstances: when the whole
MccE492 genetic system was expressed; when expressing
the hyperamyloidogenic mutants P57A and P59A from the
pETAB cassette; and when the wild-type form was expressed
from the abovementioned cassette in the presence of np220,
a plasmid expressing the genetic determinants encoded in the
MccE492 cluster with the exception of the structural gene. These
observations suggest that a cluster-encoded factor could act
nucleating or promoting MccE492 amyloid formation in vivo.
Although at ﬁrst sight this result may appear as unexpected, the
general behavior of MccE492 amyloid formation is similar to
the well-characterized curli amyloid system, for the following
reasons: ﬁrst, extracellular in vivo amyloid formation by CsgA
requires an amyloid minor component, the nucleator CsgB
(Chapman et al., 2002; Hammer et al., 2007), so it is perfectly
plausible that MccE492 as well may require the presence of a
nucleator for in vivo amyloid formation; second, both puriﬁed
CsgA and MccE492 can form amyloids in vitro with the typical
kinetics that has a lag, growth and stationary phase (Bieler
et al., 2005; Wang et al., 2007). The requirements for amyloid
formation in vitro seems to be less restrictive because there
is no need of another component, probably because the use
of high protein concentrations overcomes the requisite of a
nucleator; and third, the duration of the lag phase of both
proteins can be signiﬁcantly shortened in vitro by the addition
of sonicated preformed ﬁbrils (Wang et al., 2007; Marcoleta
et al., 2013). In the same line, the origin of the few single
polar inclusions observed in cells carrying np220 could be
explained by the aggregation of a factor such as CsgB, that
also has amyloid properties (Hammer et al., 2007). Currently,
we are working on the identiﬁcation of the putative nucleator
factor.
Whether intracellular MccE492 aggregation has a
physiological role, and how its occurrence aﬀects the cellular
metabolism, are issues that have to be investigated. Regarding
the latter, there are examples indicating that the accumulation
of amyloid inclusion bodies are toxic for E. coli cells, as seen
after overexpression of hyperamyloidogenic variants of RepA
and CsgA (Fernández-Tresguerres et al., 2010; Wang et al.,
2010). Moreover, it was shown that the identity of residues
ﬂanking an aggregation prone region (σ32β) fused to GFP
had a signiﬁcant eﬀect on bacterial growth, where fusions
harboring σ32β ﬂanked by its natural gatekeepers displayed the
greatest competitive ﬁtness (Beerten et al., 2012). The impact
of intracellular amyloid accumulation over cellular functions
makes necessary the existence of cellular mechanisms controlling
its occurrence. In this respect, chaperone machineries seem to
play an important role. In the case of the RepA-WH1(A31V)
prionoid, it was shown that DnaK but not ClpB participates in
the remodeling of amyloid inclusions, controlling the transition
between mild toxic comet-shaped aggregates and highly toxic
globular particles (Gasset-Rosa et al., 2014). In contrast, the
disaggregase activity of the ClpB chaperone is required to
propagate the yeast prion [PSI+] in E. coli cells, probably
by means of fragmenting higher order intracellular amyloid
aggregates to generate smaller seed particles (propagons) that
can be inherited to daughter cells during cell division (Yuan et al.,
2014). This apparently controversial role of ClpB chaperone
in modulating amyloid formation in E. coli cells points out
that amyloids formed of proteins from diﬀerent origins not
necessarily are subject of the same control mechanisms, even
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when they are expressed in the same host. Additionally, it
has been demonstrated for curli that an eﬃcient secretion
system and chaperone network ensures that CsgA does not form
intracellular amyloid aggregates.Moreover, amyloid formation in
the periplasm is prevented by the CsgC protein, which selectively
inhibited aggregation of CsgA and also α-synuclein (Evans and
Chapman, 2014; Evans et al., 2015). We are currently working
in establishing the impact of MccE492 intracellular amyloid
formation on the cellular metabolism, and the potential role
of chaperones or other factors in controlling this phenomenon.
In this regard, preliminary observations show that MccE492
intracellular amyloid accumulation does not seem to have the
highly toxic eﬀects observed for other amyloids such as the RepA-
WH1(A31V) prionoid. This suggests that MccE492 intracellular
amyloid formation may have a role sequestering potentially
harmful soluble or oligomeric forms, operating in a similar way as
the extracellular toxin inactivation process. In addition, the fact
that wild-type amyloid inclusions are observed only when the
whole genetic cluster of MccE492 is expressed further support
the notion that this phenomenon may have a physiological
role. It is important to point out that formation of intracellular
amyloid inclusions seems to be a dynamic process, because part
of the expressed protein is exported, even in the case of the
hyperamyloidogenic mutants. Thus, the formation of amyloid
inclusions could be the consequence of MccE492 accumulation
because of a limited exporting capacity. Also, although MccE492
expressed from the whole cluster context have a high tendency
to form intracellular amyloid inclusions, it could be possible that
other factors like chaperones ensure solubility for exporting a
proportion of the produced bacteriocin.
One further aspect to be considered is if the immunity protein
MceB plays any role in MccE492 intracellular amyloidogenesis.
Since the expression of MccE492 in the absence of its immunity
protein is lethal to the cell (Bieler et al., 2006), both proteins
had to be co-expressed in all the experiments, hampering the
possibility to directly compare MccE492 amyloid formation in
presence or absence of MceB. However, we believe that it is
very unlikely that this protein participates in the amyloidogenic
process, because MceB is an integral membrane protein with
three transmembrane helixes and not detected in the cytoplasm
(Lagos et al., 1999), therefore the neutralization of MccE492
by MceB does not occurs in this compartment. Although the
exact mechanism by which the immunity protein neutralizes
the MccE492 pore-forming activity is unknown, the interaction
would occur at the moment that MccE492 is inserted into
the inner membrane preventing the correct insertion to form
the pore. On the other hand, this protein does not form
inclusions by itself, because when co-expressed with the
wild type or hypo-amyloidogenic mutants no inclusions were
observed.
MccE492 has advantageous properties for its use as a model
to understand amyloid formation and its consequences. First,
it is a small protein (84 amino acids), which allows the study
of its amyloid behavior using variants of the full peptide, and
not only regions or domains of the protein related with amyloid
formation. Second, it polymerizes in a shorter time scale than
other amyloidogenic proteins, and ﬁnally, it can be easily puriﬁed
from culture supernatants. These properties, and the use of
the intracellular amyloid formation phenomenon to screen for
defects in amyloid formation, constitute a model useful to
study the eﬀect of extrinsic and cellular factors involved in the
amyloidogenesis of this and possibly other proteins that can be
expressed in E. coli.
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